P&G said net sales for fiscal 2025 Q3 (January–March) were $19.8 billion, down 2% from the prior year, and organic sales, which exclude the effects of foreign exchange and acquisitions and divestitures, rose 1%. Diluted and core EPS were each $1.54, up 1%.

1. 01

   P&G said net sales for fiscal 2025 Q3 (January–March) were $19.8 billion, down 2% from the prior year, and organic sales, which exclude the effects of foreign exchange and acquisitions and divestitures, rose 1%. Diluted and core EPS were each $1.54, up 1%.

2. 02

   The company said reported gross margin for Q3 fell 20 basis points from the prior year, SG&A as a percentage of sales declined 120 basis points, and operating margin rose 90 basis points. Operating margin was 23.0%.

3. 03

   Procter & Gamble said operating cash flow for Q3 was $3.7 billion, net earnings were $3.8 billion, and adjusted free cash flow productivity was 75%. In the same quarter, it returned $3.8 billion to shareowners through $2.4 billion in dividend payments and $1.4 billion in share repurchases.

4. 04

   The company said it expects all-in sales for fiscal 2025 to be roughly in line with the prior year, with organic sales growth of about 2%. It expects core EPS of $6.72 to $6.82 (growth of 2 to 4%). It maintained its guidance for about $10 billion in dividend payments and share repurchases of $6 to $7 billion.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.